Yahoo Finance 
The Global Type 2 Diabetes Market is expected to grow by $39.37 bn during 2023-2027, accelerating at a CAGR of 10.94% during the forecast period
Global Type 2 Diabetes Market 2023-2027 The analyst has been monitoring the type 2 diabetes market and it is poised to grow by $39. 37 bn during 2023-2027, accelerating at a CAGR of 10.
New York, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Type 2 Diabetes Market 2023-2027" - https://www.reportlinker.com/p02577271/?utm_source=GNW
94% during the forecast period. Our report on the type 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of diabetes, irse in prevalence of obesity and changing lifestyles, and recent product approvals.
The type 2 diabetes market is segmented as below:
By Drug Class
• Insulin
• DPP-4 inhibitor
• GLP-1 receptor agonists
• SGLT-2 inhibitors
• Others
By Distribution Channel
• Retail pharmacies
• Hospital pharmacies
• Online pharmacies
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing geriatric population as one of the prime reasons driving the type 2 diabetes market growth during the next few years. Also, an increase in awareness of diabetes and growth initiatives and innovations in therapies will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the type 2 diabetes market covers the following areas:
• Type 2 diabetes market sizing
• Type 2 diabetes market forecast
• Type 2 diabetes market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading type 2 diabetes market vendors that include Amgen Inc., AstraZeneca Plc, Baxter International Inc., Biocon Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Daiichi Sankyo Co. Ltd., DM Pharma Marketing Pvt. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson and Johnson, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Practo Technologies Pvt. Ltd., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Tonghua Dongbao Pharmaceutical Co. Ltd. Also, the type 2 diabetes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Read the full report: https://www.reportlinker.com/p02577271/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
